Cancer of the Prostate Clinical Trials
0 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled188 locationsNCT07028853
Recruiting
Not Applicable
Investigation of Impact of AI on Prostate Cancer Workflow
Prostate CancerProstatic NeoplasmCancer of the Prostate+1 more
Case Comprehensive Cancer Center150 enrolled1 locationNCT07084779
Recruiting
Not Applicable
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Prostate CancerCancer of the Prostate
Washington University School of Medicine40,000 enrolled1 locationNCT07109427
Recruiting
Not Applicable
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
AnxietyCancer of the Prostate
St. Mary's Research Center, Canada376 enrolled2 locationsNCT06363266